Table 1.
Baseline characteristics of study cohort. Values are medians (interquartile ranges) unless stated otherwise
| Characteristics | Overall (n=3489) | Trans women (n=2260) | Trans men (n=1229) |
|---|---|---|---|
| Age (years) | 47 (31-57) | 51 (38-60) | 39 (26-51) |
| Age at start of hormone treatment (years) | 28 (21-38) | 31 (23-41) | 23 (19-31) |
| % (No) white | 96.5* (2509) | 96.7† (1579) | 96.3‡ (930) |
| % (No) ever smokers* | 38.9 (1356) | 39.1 (884) | 38.4 (472) |
| BMI§ | 22.9 (20.5-26.2) | 22.7 (20.4-25.6) | 23.2 (20.7-27.3) |
| % (No) gonadectomy | - | 68.9 (1556) | 68.5 (842) |
| Oestradiol levels (pmol/L) | - | 217¶ (129-335) | 125** (78-176) |
| Testosterone levels (nmol/L) | - | 1.3†† (0.8-1.3) | 23.3‡‡ (15.9-35.2) |
| Person time (years) | 12 (4-22) | 13 (5-23) | 8 (3-20) |
| Total person time (years) | 48 874 | 33 991 | 14 883 |
Data available for *2599 people, †1633 people, ‡966 people, §2201 people, ¶1521 people, ††1334 people, **919 people, ‡‡924 people of cohort.